Flow Cytometry in Oncology and Immunology Market: Growth Drivers and Outlook
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Flow Cytometry In Oncology And Immunology Market Over The 2026–2030 Period?
The flow cytometry in oncology and immunology market size has seen rapid growth in recent years. It is anticipated to expand from $2.32 billion in 2025 to $2.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.2%. This historical expansion can be linked to several factors, including an increase in cancer research funding, the development of immunotherapy, the presence of advanced cytometry platforms, a rise in clinical trial activity, and an escalating demand for immune monitoring.
The flow cytometry in oncology and immunology market is projected for substantial expansion over the next few years. Its valuation is anticipated to climb to $3.82 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.5%. This growth throughout the forecast period is fueled by several factors, including the rising demand for personalized oncology diagnostics, the integration of genomic data, advancements in immuno-oncology therapies, the enlargement of clinical research pipelines, and progress in multiplex analysis. Furthermore, significant trends expected during this timeframe involve an increasing adoption in cancer biomarker identification, broader use in immune cell profiling, the expansion of minimal residual disease detection capabilities, a growing application within translational research, and the integration of high-dimensional data analysis techniques.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Drivers Are Fueling The Growth Of The Flow Cytometry In Oncology And Immunology Market?
The increasing occurrence of HIV/AIDS is anticipated to boost the growth of flow cytometry in the oncology and immunology market moving forward. HIV is a virus that targets the body’s immune system, specifically CD4 cells, which are white blood cells vital for combating infections. If left untreated, HIV can eventually lead to AIDS, which represents the final stage of HIV infection. Flow cytometry serves as a potent method utilized in HIV/AIDS research and clinical settings to examine and characterize cells, particularly immune cells, based on their physical and chemical attributes. This technology can also pinpoint latently infected T cells that contain the HIV genome but are not actively producing the virus. For example, in July 2024, UNAIDS, a UN program situated in Switzerland, stated that in 2023, approximately 39.9 million people were living with HIV globally, an increase from 39.0 million in 2022. Hence, the escalating prevalence of HIV/AIDS is propelling the flow cytometry market within oncology and immunology.
How Is The Flow Cytometry In Oncology And Immunology Market Categorized Across Its Segment Groups?
The flow cytometry in oncology and immunology market covered in this report is segmented –
1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
Subsegments:
1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation
What Trends Are Influencing The Flow Cytometry In Oncology And Immunology Market?
Leading firms within the flow cytometry sector, specifically those engaged in the oncology and immunology market, are prioritizing the creation of advanced solutions, like spectral flow cytometry, to secure a stronger market position. This technology, spectral flow cytometry, operates by capturing the complete emission spectrum from individual fluorescent markers instead of relying on fixed, narrow-band signal detection, thus facilitating advanced, multiparametric cell analysis with a significantly increased number of parameters. An illustrative example occurred in May 2024 when Agilent Technologies, a life science company headquartered in the US, unveiled its NovoCyte Opteon spectral flow cytometer. This system is capable of accommodating three to five lasers, features up to 73 detectors, and allows for the examination of more than 40 markers within a single experimental run. Such a system significantly improves the capabilities for in-depth immunophenotyping investigations in both oncology and immunology research. Its benefits encompass greater flexibility in panel configuration, diminished spectral overlap, and enhanced signal resolution. Nevertheless, a drawback is its need for more intricate data unmixing algorithms, which could extend the time required for analysis.
Which Firms Are Influencing Competition In The Flow Cytometry In Oncology And Immunology Market?
Major companies operating in the flow cytometry in oncology and immunology market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, Miltenyi Biotec, Luminex Corporation, Q2 Solutions LLC, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason
Get The Full Flow Cytometry In Oncology And Immunology Market Report:
Which Geographic Region Dominates The Flow Cytometry In Oncology And Immunology Market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2025. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Flow Cytometry In Oncology And Immunology Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Flow Cytometry In Oncology And Immunology Market 2026, By The Business Research Company
Tumor Infiltrating Lymphocytes Market Report 2026
Flow Cytometry Market Report 2026
https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report
Circulating Tumor Cells Market Report 2026
https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
